Long-term and acute safety of a novel orally administered combination drug product containing milbem...
Long-term and acute safety of a novel orally administered combination drug product containing milbemycin oxime and lotilaner (Credelio® Plus) in juvenile and adult dogs
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
The combination of milbemycin oxime (MO) and lotilaner (Credelio
Plus) is a novel systemic endectocide that provides month-long effectiveness in dogs after a single oral treatment. The safety of Credelio
Plus flavored chewable tablets was investigated in three target animal safety studies. Two studies (one in juveniles and one in adults) eval...
Alternative Titles
Full title
Long-term and acute safety of a novel orally administered combination drug product containing milbemycin oxime and lotilaner (Credelio® Plus) in juvenile and adult dogs
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_9f190318a7b24bc69de324f37af38ae9
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9f190318a7b24bc69de324f37af38ae9
Other Identifiers
ISSN
1756-3305
E-ISSN
1756-3305
DOI
10.1186/s13071-021-04760-z
